Oncology Competitive Intelligence Leaders
Solid Tumor Reports
ONCrg’s suite of integrated, evergreen resources keep pace with rapidly shifting landscapes in 14 solid tumor drug markets. Dedicated tumor experts provide incisive coverage of 13 major medical congresses, highly relevant monthly CI surveillance, and detailed pipelines incorporating both visual landscapes and granular analysis.
In the fast-moving and challenging field of immuno-oncology, ONCrg is the CI vendor of choice for expert evaluation of basic, translational, and clinical data. Our I-O and tumor-area experts continuously collaborate assessing both emerging assets and products that can rapidly change the standard-of-care across 21 solid and hematologic malignancies.
Hematologic Malignancy Reports
ONCrg’s easily digestible competitive landscapes include visual treatment and development algorithms by cancer subtype and line of therapy. These detailed pipeline analyses are enriched and refreshed with our best-in-class medical conference coverage and rigorous monthly surveillance reports to provide unparalleled, year-round CI.